Sponsor |  squiffy2 | Jul 21, 7:13am |
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School has reached an important milestone with the news that the full cohort of 493 patients with multiple sclerosis (MS) has been recruited to the programme.
CUPID is a clinical trial part-funded by the MS Society, which will evaluate whether tetrahydrocannabinol (THC) - the main active ingredient in the cannabis plant and one of many compounds found in the organism - is able to slow the progression of MS.
It is an important study for people with MS, because current treatments either target the immune system in the early stages of MS, or ease specific symptoms such as muscle spasms or bladder problems................
For the full report please go to MSRC: MS Research News : Drugs : Cannabis And Cannabinoid Research - msrc.co.uk/index.cfm [msrc.co.uk/index.cfm] |
|
Multiple Sclerosis → Discussion